NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
09/09/2022
Back to search
Official data from USPTO
RP ROBINSON PHARMA, INC.
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
29
Latest update
09/09/2022
Trademark type
Combined
Nice classes
40
Filing date
11/07/2011
Registration date
07/03/2012
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/09/2022
Last transaction
09/09/2022
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
First use anywhere
06/08/2010
First use in commerce
06/08/2010
Drawing code
3
Owner type
03
Owner location
SANTA ANA, CA
Examiner
KEAM,ALEX S
Law office
M50
Current location
GENERIC WEB UPDATE
Mark description
The mark consists of the letter "R" in white above the letter "P" in black within a circle outlined in red and shaded in red, white and black, the black and white portions in the middle comprising a stylized design of a pill. Below the shaded circle and letters "RP" is the wording "ROBINSON PHARMA, INC." in black.
Holders and representatives
Holders
T. N. (pessoa física)
Representatives
TAM NGUYEN
Technical classification
Nice Classes
Class 40
Vienna Codes
No Vienna codes available.
Goods and services
Class 40
Manufacturing services for others in the field of pharmaceutical productsdietary vitamins and nutritional supplements
Publications
History of USPTO decisions and trademark events.
29 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
09/09/2022
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
09/09/2022
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09/09/2022
E89R
TEAS SECTION 8 & 9 RECEIVED
03/17/2022
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
07/03/2021
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
08/15/2017
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
08/15/2017
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
08/14/2017
E815
TEAS SECTION 8 & 15 RECEIVED
07/05/2017
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/05/2017
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
07/03/2017
R.PR
REGISTERED-PRINCIPAL REGISTER
07/03/2012
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/17/2012
PUBO
PUBLISHED FOR OPPOSITION
04/17/2012
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/28/2012
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
03/09/2012
ALIE
ASSIGNED TO LIE
03/09/2012
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/21/2012
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/17/2012
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/17/2012
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/17/2012
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
02/17/2012
GNRT
NON-FINAL ACTION E-MAILED
02/17/2012
CNRT
NON-FINAL ACTION WRITTEN
02/17/2012
DOCK
ASSIGNED TO EXAMINER
02/09/2012
MDSC
NOTICE OF DESIGN SEARCH CODE MAILED
11/15/2011
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/13/2011
NWAP
NEW APPLICATION ENTERED
11/10/2011
Continuous trademark protection
Get notified about every new filing that threatens RP ROBINSON PHARMA, INC. or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.